Inhaled Insulin in Development
Bristol-Myers Squibb and QDose have announced a collaboration to develop inhaled insulin.
QDose is now involved in early work on this new form of insulin.
Bristol-Myers Squibb will obtain worldwide exclusive rights to the product and, with skupport from QDose, will take the lead in development, manufacturing and commercialization of the licensed product.
-Bristol-Myers Squibb news release, September 2003Click Here To View Or Post Comments